Unexpected diagnosis of COVID-19-associated disorders by SARS-CoV-2-specific serology
Detection Principle
ImmunoAssay-Antibody
Target
N protein
Testing Method Category
Other Immuno assay
Testing Method
CE IVD-labeled Abbott SARS-CoV-2 IgG assay
Testing Method - Additional Info
Evaluation the analytical performances of the CE IVD-labeled Abbott SARS-CoV-2 IgG assay (Des Plaines, IL, USA) carried out with the automated Abbott Architect™ i2000
Reported Performance
Sensitivity: 94%; Specificity: 100%;
Sample Size
117 sera
Peer-reviewed
yes
The database contains available information from scientific literature that is being updated periodically. Please note that the provided information (as retrieved from analysed papers) is provided only for devices commercially available with CE-IVD mark. Acknowledgements